Publications

In the fast-paced world of medical device manufacturing, safety is always a top priority. However, safety doesn’t just come from high-quality engineering or innovative design. It also hinges on clear communication, especially when it comes to labeling, instructions for use (IFUs), and safety documentation. With the implementation of the EU Medical Device Regulation (MDR 2017/745) and In-vitro Diagnostic Regulation (IVDR 2017/746), these materials are now subject to more stringent localization requirements than ever before.

As 2025 unfolds, the field of multimedia localization is rapidly evolving, shaped by advancements in AI, machine learning, and cloud-based platforms. At Janus Worldwide, we are committed to staying at the forefront of these innovations to deliver cutting-edge localization solutions that ensure global reach and cultural relevance for our clients.

In today’s globalized world, companies are expanding beyond their domestic markets at an unprecedented rate. With this growth comes the need to communicate effectively with diverse audiences, and that’s where localization of marketing materials becomes crucial. At Janus Worldwide, we are committed to helping brands adapt their message to resonate across languages and cultures, ensuring that each communication is not just a translation, but a strategic, culturally-aligned tool for success.

In a world where speed and quality of translation is becoming a strategic advantage for businesses, Janus Worldwide reaffirms its reputation as a technology leader in the industry. We are pleased to introduce LEXA, a new cloud-based platform that combines the best solutions from the company and global machine translation providers into a single intelligent system.

As companies expand across borders, localization has become essential – not just an added value. Success now hinges on delivering culturally relevant experiences, not just translated content.

In clinical research, translation is essential. Every patient deserves to fully understand their consent. Unfortunately, many critical documents like informed consent forms and trial instructions are inadequately translated, leading to confusion, misinformed choices, and potential safety risks.

Janus Worldwidelanguage services and translation technology provider has been named by CSA Research as one of the 2025 Global and Regional Market Leaders. The recognition is based on independently verified 2024 revenue data and highlights companies playing a significant role in the global language services and technology market.

In an era of digital transformation, companies seeking sustainable growth are turning to innovative solutions that streamline processes, increase productivity and deliver the highest quality of service. At Janus Worldwide, the answer to these challenges is the Maia project, an internal AI ecosystem that integrates artificial intelligence and key enterprise tools into a single entity.

Modern automated translation technologies are developing rapidly, and two main approaches have come to the fore today: machine translation and translation using artificial intelligence.

Janus successfully uses various automated translation technologies: machine translation (MT) and translation using artificial intelligence. As well as advantages, both technologies have their disadvantages, which are offset by certain customization methods, making each technology suitable for specific translation tasks.